[Clinico-pharmacological test of a new penicillinase-stable penicillin, pyrazocillin, F 75 ].
D002180:Candidiasis, Oral / Q000139:chemically induced; D004342:Drug Hypersensitivity; D004355:Drug Stability; D004415:Dyspepsia / Q000139:chemically induced; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D010405:Penicillinase; D010406:Penicillins / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D011720:Pyrazoles / Q000494:pharmacology*; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects*; D014839:Vomiting / Q000139:chemically induced
D010406:Penicillins; D011720:Pyrazoles; D010405:Penicillinase
Kliniko-pharmakologische Prüfung eines neuen penicillinase-stabilen Penicillins, Pyrazocillin, F 75.